Recruiting

Spectrosense EVA

Sponsor:

Rauscher, Gregory E., M.D. PA

Code:

NCT01994681

Conditions

Pancreatic Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Study Details

Brief summary:

Volatile Organic Compounds (VOC) in human breath are captured and analyzed by the Spectrosense EVA system, which is combination of a gas chromatography (GC) and software algorithm. The objective is to obtain a set or sets of VOC bio-markers that will provide the best discrimination between Pancreatic Cancer sick population and healthy population. The gold standard for identifying sick/healthy population is biopsy proven Pancreatic cancer.

Conditions

Pancreatic Cancer

Study ID

NCT01994681

Start date

Oct, 2013

Status verified date

Dec, 2013

Primary completion date

Oct, 2014

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Pancreatic cancer Group

Inclusion Criteria:

  • Age from 18 years old
  • Pancreatic cancer positive biopsy
  • Before any treatment
  • Signed Informed Patient Consent

Exclusion Criteria:

  • Age under 18 years old
  • Neoadjovant treatment
  • Post surgery for Pancreatic cancer
  • A history of any other cancer type, except skin cancer that is not melanoma

Healthy Group

Inclusion Criteria:

  • Healthy patients
  • No history of Pancreatic cancer
  • Signed Informed Patient Consent

Exclusion Criteria:

  • History of Pancreatic cancer
  • Pancreatic cancer background in the family
  • A history of any other cancer type, except skin cancer that is not melanoma

Study Design

Enrollment

100 participants

Anticipated

Interventions and Outcome Measures

Arms

Pancreatic Cancer

Healthy

Primary outcome measure

  • Obtaining a set or sets of VOC bio-markers that will provide the best discrimination between Pancreatic Cancer sick population and healthy population. [ Time Frame: Baseline ]

Central Contacts and Locations

Central contacts

Locations

Hackensack University Medical Center

Recruiting

Hackensack, New Jersey, United States, 07601

More Information

Sponsor

Rauscher, Gregory E., M.D. PA

Last update posted

Dec 5, 2013

Last verified

Dec, 2013

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Rauscher, Gregory E., M.D. PA on 2013-12-05.